• Explore /
  • Poster
  • / A phase I/II study of lymphodepletion plus adoptive cell transfer (ACT) with T cells transduced with CXCR2 and NGFR followed by high dose interleukin-2 (IL-2) in patients with metastatic melanoma (MM).

A phase I/II study of lymphodepletion plus adoptive cell transfer (ACT) with T cells transduced with CXCR2 and NGFR followed by high dose interleukin-2 (IL-2) in patients with metastatic melanoma (MM).

Abstract Poster

Authors

null

Rodabe Navroze Amaria

The University of Texas MD Anderson Cancer Center, Houston, TX

Rodabe Navroze Amaria , Cara L. Haymaker , Chantale Bernatchez , Marie-Andree Forget , Vruti Patel , Wen-Jen Hwu , Michael A. Davies , Sapna Pradyuman Patel , Adi Diab , Isabella Claudia Glitza , Hussein Abdul-Hassan Tawbi , Scott Eric Woodman , Jennifer Ann Wargo , Merrick I. Ross , Jeffrey Edwin Lee , Jeffrey E. Gershenwald , Janice N. Cormier , Richard Eldon Royal , Anthony Lucci Jr., Patrick Hwu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT 01740557

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS9594)

DOI

10.1200/JCO.2016.34.15_suppl.TPS9594

Abstract #

TPS9594

Poster Bd #

197b

Abstract Disclosures

Similar Posters

First Author: Rodabe Navroze Amaria

First Author: Rosa Nadal

First Author: Rongsu Qi

First Author: Rosa Nadal